Deflazacort CAS NO.14484-47-0

We are a manufacturer based in China. We specialize in providing high-quality Deflazacort CAS NO.14484-47-0 for industrial clients across various sectors. Whether you need chemicals consultation or technical support, our team is here to help.

Category:Active Pharmaceutical Ingredients   Own Brand:MT  /MOQ:100KG  /From China/  B2B only.

Advantage:Customizable,Please tell me your specific needs↓↓↓

Introduction

Catalog ID80017766

CAS NO.14484-47-0

Purity 98%

MDL NumberMFCD00866106

EINEC238-483-7

Molecular formula C25H31NO6

Molecular weight 441.5167

Melting point: 255~257°C

Aspect Details
Mechanism of Action Deflazacort is a corticosteroid prodrug that is rapidly converted to its active metabolite, 21-deflazacort. It binds to glucocorticoid receptors, exerting anti-inflammatory and immunosuppressive effects.
Pharmacokinetics – Absorption: Rapidly absorbed after oral administration, with peak plasma concentration occurring within 1-2 hours.<br>- Distribution: Volume of distribution is approximately 204 ± 84 L.<br>- Metabolism: Deacetylated by plasma esterases to 21-deflazacort, further metabolized by CYP3A4.<br>- Elimination: Primarily excreted in urine (70%) and feces (30%) within 24 hours.<br>- Half-Life: 1.1 to 1.9 hours.
Indications Used to treat Duchenne muscular dystrophy (DMD) in patients aged 5 years and older. It is also used off-label for conditions such as rheumatoid arthritis, nephrotic syndrome, systemic lupus erythematosus, and transplantation.
Adverse Effects Common side effects include increased risk of infections, hypertension, fluid retention, behavioral and mood disturbances, decreased bone mineral density, and ophthalmic effects such as cataracts.
Storage Conditions Store at room temperature (20°C to 25°C; 68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). Discard any unused oral suspension after 1 month of first opening the bottle.
Special Considerations – Gradual Dose Reduction: Abrupt discontinuation may lead to adrenal insufficiency.<br>- Infection Risk: Patients should avoid exposure to chickenpox or measles and seek medical advice if exposed.<br>- Cardiovascular/Renal Effects: Monitor blood pressure and consider dietary salt restriction if fluid retention occurs.<br>- Bone Health: Prolonged use may increase the risk of osteoporosis.<br>- Growth in Children: Deflazacort may have less negative impact on growth compared to other corticosteroids.

Disclaimer: The above content is for reference and communication only among industry insiders, and does not guarantee its accuracy or completeness. According to relevant laws and regulations and the regulations of this website, units or individuals who purchase related items should obtain valid qualifications and qualification conditions.

If you're ready to take the next step, Leave your message below and we’ll reply soon. 20+ years of chemical manufacturing & export experience, a partner you can trust.

Inquiry

                               

    Factory & Shipment

    chemical factory
    chemical factory
    Powder Coatings
    chemical factory